Related Experiment Video
Updated: May 31, 2026
10:54
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
Molybdenum-99/technetium-99m management: race against time
Annals of Nuclear Medicine
|July 6, 2011
Summary
Molybdenum-99 (Mo-99) is crucial for diagnostic nuclear medicine, decaying into technetium-99m (Tc-99m). Fragile Tc-99m supplies threaten patient care, necessitating solutions for this vital diagnostic radionuclide.
Area of Science:
- Nuclear medicine
- Radiochemistry
- Medical imaging
Background:
- Molybdenum-99 (Mo-99) is the essential parent radionuclide for technetium-99m (Tc-99m).
- Tc-99m is utilized in over 30 million diagnostic investigations globally each year.
- Recent years have seen persistent fragility in Tc-99m supply chains.
Discussion:
- The critical role of Mo-99/Tc-99m in modern diagnostics is highlighted.
- The recurring supply shortages of Tc-99m pose a significant risk to global patient care.
- The letter addresses the urgent need for strategies to ensure a stable supply of this indispensable radionuclide.
Key Insights:
- Tc-99m is indispensable for a vast number of annual medical imaging procedures worldwide.
- The reliability of Mo-99/Tc-99m supply chains has been compromised, impacting healthcare.
- Proactive measures are required to mitigate future shortages of this key diagnostic isotope.
Outlook:
- Exploring alternative Mo-99 production methods and supply chain diversification is critical.
- Developing strategies to manage and stabilize the global Tc-99m supply is paramount.
- Ensuring uninterrupted patient access to Tc-99m-based diagnostics requires collaborative international efforts.
